Table 3 Symptoms, precipitating factors, and co-morbidities for the study population
From: Acute hepatic porphyria in Denmark; a retrospective study
Symptoms | n (%) | Precipitating factor | n (%) | Co-morbidities | n (%) |
|---|---|---|---|---|---|
Abdominal pain | 36 (94.7%) | Unknown | 15 (39.5%) | None | 84 (65.1%) |
Nausea, vomiting | 11 (28.9%) | Alcohol | 6 (15.8%) | Hypertension | 19 (14.7%) |
Weakness | 5 (13.2%) | Stress | 10 (26.3%) | Reduced eGFR | 9 (7.0%) |
Constipation | 6 (15.8%) | Medication | 7 (18.4%) | Headache | 2 (1.6%) |
Anxiety, depression | 3 (7.9%) | Menstruation/hormonal | 2 (5.3%) | Paresis | 0 (0.0%) |
Diarrhea | 4 (10.5%) | Fasting | 4 (10.5%) | Other | 36 (27.9%) |
Seizures | 3 (7.9%) | Infection | 10 (26.3%) | ||
Paresis, neurological disturbance | 12 (31.6%) |